Remission therapy of cancer with isoflavonoids
AssigneeMarshall Edwards, Inc.
InventorsAyesha B. Alvero, Daniel P. Gold, Gil G. Mor
Life of this patent
Estimating the term…
Abstract
Provided herein is a method of reducing incidences of cancer recurrence. The method involves administering to an individual in cancer remission an isoflavonoid. In specific instances, the treated individual is in remission from epithelial cancer, such as ovarian cancer or breast cancer.
Claims21
A method of reducing incidences of cancer recurrence, comprising administering to an individual in cancer remission an effective amount of a compound of formula (I):
- wherein
- R1, R3 and R4 are independently hydrogen, hydroxy, halo, haloalkyl, NR12R13, C1-6 alkoxy, C1-6 fluoroalkyl or C1-6 alkyl;
- R2 and R5 are independently hydrogen, hydroxy, halo, haloalkyl, NR12R13, C1-6 alkoxy, C1-6 fluoroalkyl or C1-6 alkyl;
- R6 is hydrogen;
- R7 is hydrogen, haloalkyl, halo or C1-6 alkyl;
- R9 is hydroxy or C1-6 alkoxy;
- R10 is hydrogen;
- the drawing “” and R11 together represent a double bond or the drawing “” represents a single bond and R11 is hydrogen or hydroxy;
- R12 and R13 are independently hydrogen, C1-6 alkyl or trialkyl silyl;
- or salts or a derivative thereof;
- and
- wherein the compound of formula (I) reduces cancer cell proliferation.
(canceled)
A method of inhibiting loss of cancer remission comprising contacting an individual having cancer with an effective amount of formula (I):
- wherein
- R1, R3 and R4 are independently hydrogen, hydroxy, halo, haloalkyl, NR12R13, C1-6 alkoxy, C1-6 fluoroalkyl or C1-6 alkyl;
- R2 and R5 are independently hydrogen, hydroxy, halo, haloalkyl, NR12R13, C1-6 alkoxy, C1-6 fluoroalkyl or C1-6 alkyl;
- R6 is hydrogen;
- R7 is hydrogen, haloalkyl, halo or C1-6 alkyl;
- R9 is hydroxy or C1-6 alkoxy;
- R10 is hydrogen;
- the drawing “” and R11 together represent a double bond or the drawing “” represents a single bond and R11 is hydrogen or hydroxy;
- and
- R12 and R13 are independently hydrogen, C1-6 alkyl or trialkyl silyl;
- or salts or a derivative thereof.
(canceled)
A method of inducing apoptosis in a cancer-related stem cell, the method comprising contacting said stem cell with a compound of formula (I):
- wherein
- R1, R3 and R4 are independently hydrogen, hydroxy, halo, haloalkyl, NR12R13, C1-6 alkoxy, C1-6 fluoroalkyl or C1-6 alkyl;
- R2 and R5 are independently hydrogen, hydroxy, halo, haloalkyl, NR12R13, C1-6 alkoxy, C1-6 fluoroalkyl or C1-6 alkyl;
- R6 is hydrogen;
- R7 is hydrogen, haloalkyl, halo or C1-6 alkyl;
- R9 is hydroxy or C1-6 alkoxy;
- R10 is hydrogen;
- the drawing “” and R11 together represent a double bond or the drawing “” represents a single bond and R11 is hydrogen or hydroxy;
- and
- R12 and R13 are independently hydrogen, C1-6 alkyl or trialkyl silyl;
- or salts or a derivative thereof.
(canceled)
-38. (canceled)
Dependencies are inferred from the claim text.